Summary

This article discusses variables that put patients who are undergoing aortic valve replacement at increased risk; the impact of these factors on morbidity and mortality; and the validity of standardized risk algorithms. Additional topics include aortic valve technology, mitral valve technology, and decision-making strategies in patients with advanced valvular disease.